Claudette Falato

Gene Expression Signatures and Immunohistochemical Subtypes Add Prognostic Value to Each Other in Breast Cancer Cohorts

Arian Lundberg, Linda S. Lindström, J. Chuck Harrell et al. · Clinical Cancer Research · 2017 · 56 citations

Medicine, Cancer Biology, Oncology +17

Patritumab deruxtecan in untreated hormone receptor-positive/HER2-negative early breast cancer: final results from part A of the window-of-opportunity SOLTI TOT-HER3 pre-operative study

Mafalda Oliveira, Claudette Falato, Juan Miguel Cejalvo et al. · Annals of Oncology · 2023 · 41 citations · Full text

Medicine, Oncology, Pharmacology +17

Ki67 measured in metastatic tissue and prognosis in patients with advanced breast cancer

Claudette Falato, Julie Lorent, Edneia Tani et al. · Breast Cancer Research and Treatment · 2014 · 29 citations

Medicine, Cancer Biology, Oncology +14

Minimally important differences for the EORTC QLQ-C30 in prostate cancer clinical trials

Eva‐Maria Gamper, Jammbe Musoro, Corneel Coens et al. · BMC Cancer · 2021 · 29 citations · Full text

Medicine, Biostatistics, Oncology +17

Patritumab deruxtecan in HER2-negative breast cancer: part B results of the window-of-opportunity SOLTI-1805 TOT-HER3 trial and biological determinants of early response

Fara Brasó‐Maristany, J.M. Ferrero-Cafiero, Claudette Falato et al. · Nature Communications · 2024 · 23 citations · Full text

Medicine, Oncology, Pharmacology +16